ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 204 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $12,120,000 | +46.6% | 226,757 | +207.8% | 0.02% | +50.0% |
| Q4 2015 | $8,265,000 | +23.1% | 73,677 | +29.2% | 0.01% | +7.7% |
| Q3 2015 | $6,714,000 | -28.8% | 57,045 | -53.2% | 0.01% | -13.3% |
| Q2 2015 | $9,428,000 | +155.1% | 121,776 | +90.6% | 0.02% | +114.3% |
| Q1 2015 | $3,696,000 | +257.8% | 63,904 | +99.4% | 0.01% | +250.0% |
| Q4 2014 | $1,033,000 | +4.3% | 32,055 | -20.7% | 0.00% | 0.0% |
| Q3 2014 | $990,000 | +46.9% | 40,438 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $674,000 | -56.5% | 40,438 | -57.4% | 0.00% | -66.7% |
| Q1 2014 | $1,549,000 | -25.8% | 95,027 | -12.5% | 0.00% | -25.0% |
| Q4 2013 | $2,089,000 | +27.8% | 108,652 | -29.4% | 0.00% | +33.3% |
| Q3 2013 | $1,634,000 | +163300.0% | 153,884 | +146456.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $120,640,000 | 41.48% |
| Palo Alto Investors LP | 2,187,242 | $247,093,000 | 13.75% |
| VHCP Management, LLC | 140,756 | $15,901,000 | 9.61% |
| HWG Holdings LP | 48,910 | $5,525,000 | 5.62% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 906,287 | $102,383,000 | 4.98% |
| Baker Brothers Advisors | 4,198,520 | $474,307,000 | 3.93% |
| Asymmetry Capital Management, L.P. | 15,591 | $1,761,000 | 2.66% |
| NEXT CENTURY GROWTH INVESTORS LLC | 496,744 | $56,117,000 | 2.42% |
| AlpInvest Partners B.V. | 11,551 | $1,305,000 | 2.17% |
| Atika Capital Management LLC | 36,000 | $4,067,000 | 2.09% |